155 related articles for article (PubMed ID: 36227718)
1. Influence of Baseline Diastolic Blood Pressure on the Effects of Systolic Blood Pressure Lowering on Cognitive Function in Type 2 Diabetes Mellitus.
Gupta A; Boucher R; Wei G; Gronseth G; Parks A; Beddhu S
Am J Hypertens; 2023 Feb; 36(2):120-125. PubMed ID: 36227718
[TBL] [Abstract][Full Text] [Related]
2. The Influence of Baseline Diastolic Blood Pressure on the Effects of Intensive Blood Pressure Lowering on Cardiovascular Outcomes and All-Cause Mortality in Type 2 Diabetes.
Ilkun OL; Greene T; Cheung AK; Whelton PK; Wei G; Boucher RE; Ambrosius W; Chertow GM; Beddhu S
Diabetes Care; 2020 Aug; 43(8):1878-1884. PubMed ID: 32366577
[TBL] [Abstract][Full Text] [Related]
3. Effects of intensive versus standard blood pressure control on domain-specific cognitive function: a substudy of the SPRINT randomised controlled trial.
Rapp SR; Gaussoin SA; Sachs BC; Chelune G; Supiano MA; Lerner AJ; Wadley VG; Wilson VM; Fine LJ; Whittle JC; Auchus AP; Beddhu S; Berlowitz DR; Bress AP; Johnson KC; Krousel-Wood M; Martindale-Adams J; Miller EC; Rifkin DE; Snyder JK; Tamariz L; Wolfgram DF; Cleveland ML; Yang M; Nichols LO; Bryan RN; Reboussin DM; Williamson JD; Pajewski NM;
Lancet Neurol; 2020 Nov; 19(11):899-907. PubMed ID: 33098800
[TBL] [Abstract][Full Text] [Related]
4. Association of JNC-8 and SPRINT Systolic Blood Pressure Levels With Cognitive Function and Related Racial Disparity.
Hajjar I; Rosenberger KJ; Kulshreshtha A; Ayonayon HN; Yaffe K; Goldstein FC
JAMA Neurol; 2017 Oct; 74(10):1199-1205. PubMed ID: 28828478
[TBL] [Abstract][Full Text] [Related]
5. Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control.
Beddhu S; Chertow GM; Cheung AK; Cushman WC; Rahman M; Greene T; Wei G; Campbell RC; Conroy M; Freedman BI; Haley W; Horwitz E; Kitzman D; Lash J; Papademetriou V; Pisoni R; Riessen E; Rosendorff C; Watnick SG; Whittle J; Whelton PK;
Circulation; 2018 Jan; 137(2):134-143. PubMed ID: 29021322
[TBL] [Abstract][Full Text] [Related]
6. Association of the Haptoglobin Gene Polymorphism With Cognitive Function and Decline in Elderly African American Adults With Type 2 Diabetes: Findings From the Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) Study.
Beeri MS; Lin HM; Sano M; Ravona-Springer R; Liu X; Bendlin BB; Gleason CE; Guerrero-Berroa E; Soleimani L; Launer LJ; Ehrenberg S; Lache O; Seligman YK; Levy AP
JAMA Netw Open; 2018 Nov; 1(7):e184458. PubMed ID: 30646354
[TBL] [Abstract][Full Text] [Related]
7. Target Blood Pressure in Patients with Diabetes: Asian Perspective.
Park S; Kario K; Park CG; Huang QF; Cheng HM; Hoshide S; Wang JG; Chen CH;
Yonsei Med J; 2016 Nov; 57(6):1307-11. PubMed ID: 27593856
[TBL] [Abstract][Full Text] [Related]
8. Blood pressure responses to hypertension treatment and trends in cognitive function in patients with initially difficult-to-treat hypertension: a retrospective subgroup analysis of the Observational Study on Cognitive Function and SBP Reduction (OSCAR) study.
Petrella RJ; Shlyakhto E; Konradi AO; Berrou JP; Sedefdjian A; Pathak A;
J Clin Hypertens (Greenwich); 2012 Feb; 14(2):78-84. PubMed ID: 22277139
[TBL] [Abstract][Full Text] [Related]
9. Influence of Baseline Diastolic Blood Pressure on the Effects of Intensive Blood Pressure Lowering: Results From the STEP Randomized Trial.
Yang R; Huang R; Zhang L; Li D; Luo J; Cai J
Hypertension; 2023 Dec; 80(12):2572-2580. PubMed ID: 37814892
[TBL] [Abstract][Full Text] [Related]
10. Association of Glycemia, Lipids, and Blood Pressure With Cognitive Performance in People With Type 2 Diabetes in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE).
Luchsinger JA; Younes N; Manly JJ; Barzilay J; Valencia W; Larkin ME; Falck-Ytter C; Krause-Steinrauf H; Pop-Busui R; Florez H; Seaquist E; ;
Diabetes Care; 2021 Oct; 44(10):2286-2292. PubMed ID: 34285097
[TBL] [Abstract][Full Text] [Related]
11. Association Between Baseline Diastolic Blood Pressure and the Efficacy of Intensive vs Standard Blood Pressure-Lowering Therapy.
Foy AJ; Filippone EJ; Schaefer E; Nudy M; Ruzieh M; Dyer AM; Chinchilli VM; Naccarelli GV
JAMA Netw Open; 2021 Oct; 4(10):e2128980. PubMed ID: 34668944
[TBL] [Abstract][Full Text] [Related]
12. Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial.
Cukierman-Yaffe T; Gerstein HC; Williamson JD; Lazar RM; Lovato L; Miller ME; Coker LH; Murray A; Sullivan MD; Marcovina SM; Launer LJ;
Diabetes Care; 2009 Feb; 32(2):221-6. PubMed ID: 19171735
[TBL] [Abstract][Full Text] [Related]
13. Obesity is associated with greater cognitive function in patients with type 2 diabetes mellitus.
Xing Z; Long C; Hu X; Chai X
Front Endocrinol (Lausanne); 2022; 13():953826. PubMed ID: 36353230
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive efficacy and tolerability of irbesartan/hydrochlorothiazide in hypertensive patients stratified by body mass index and type 2 diabetes mellitus status: a post hoc subgroup analysis of the Irbesartan/HCTZ Blood Pressure Reductions in Diverse Patient Populations trial.
Lewin AJ; Weir MR
Clin Ther; 2008 Dec; 30(12):2354-65. PubMed ID: 19167594
[TBL] [Abstract][Full Text] [Related]
15. Effects of Intensive Systolic Blood Pressure Lowering on Cardiovascular Events and Mortality in Patients With Type 2 Diabetes Mellitus on Standard Glycemic Control and in Those Without Diabetes Mellitus: Reconciling Results From ACCORD BP and SPRINT.
Beddhu S; Chertow GM; Greene T; Whelton PK; Ambrosius WT; Cheung AK; Cutler J; Fine L; Boucher R; Wei G; Zhang C; Kramer H; Bress AP; Kimmel PL; Oparil S; Lewis CE; Rahman M; Cushman WC
J Am Heart Assoc; 2018 Sep; 7(18):e009326. PubMed ID: 30371182
[TBL] [Abstract][Full Text] [Related]
16. Effect of Hypertension Duration and Blood Pressure Control During Early Adulthood on Cognitive Function in Middle Age.
Zhou H; Zhu Z; Liu C; Bai Y; Zhan Q; Huang X; Zeng Q; Ren H; Xu D
J Alzheimers Dis; 2022; 85(2):779-789. PubMed ID: 34864670
[TBL] [Abstract][Full Text] [Related]
17. The cross-sectional and longitudinal associations of diabetic retinopathy with cognitive function and brain MRI findings: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
Hugenschmidt CE; Lovato JF; Ambrosius WT; Bryan RN; Gerstein HC; Horowitz KR; Launer LJ; Lazar RM; Murray AM; Chew EY; Danis RP; Williamson JD; Miller ME; Ding J
Diabetes Care; 2014 Dec; 37(12):3244-52. PubMed ID: 25193529
[TBL] [Abstract][Full Text] [Related]
18. Association of depression with accelerated cognitive decline among patients with type 2 diabetes in the ACCORD-MIND trial.
Sullivan MD; Katon WJ; Lovato LC; Miller ME; Murray AM; Horowitz KR; Bryan RN; Gerstein HC; Marcovina S; Akpunonu BE; Johnson J; Yale JF; Williamson J; Launer LJ
JAMA Psychiatry; 2013 Oct; 70(10):1041-7. PubMed ID: 23945905
[TBL] [Abstract][Full Text] [Related]
19. Effect of canagliflozin on blood pressure and adverse events related to osmotic diuresis and reduced intravascular volume in patients with type 2 diabetes mellitus.
Weir MR; Januszewicz A; Gilbert RE; Vijapurkar U; Kline I; Fung A; Meininger G
J Clin Hypertens (Greenwich); 2014 Dec; 16(12):875-82. PubMed ID: 25329038
[TBL] [Abstract][Full Text] [Related]
20. Relationship between orthostatic blood pressure changes and intensive blood pressure management in patients with hypertension.
Pei J; Zhang H; Li Y; Yan J; Zheng K; Wang X; Zheng XL; Hu X
Heart; 2022 Dec; 109(2):111-118. PubMed ID: 36007937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
